Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DoSe iT: Clarithromycin DST vs Syrup in Children
NCT04016051Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Sep 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of clarithromycin in acute otitis media (AOM), tonsillitis, pharyngitis and 1 more (2 arms), sponsored by Grünenthal GmbH. Primary endpoints: Preparation of the medication, Dosing accuracy and 7 more. Started Sep 2004; status: completed.
02
Drugs
clarithromycin
03
Conditions
acute otitis media (AOM)tonsillitispharyngitisacute bronchitis
Beyond the preview
Go deeper on NCT04016051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04016051.